Review
Pathophysiology and management of radiation-induced xerostomia
Affiliations
- PMID: 15915820
Item in Clipboard
Review
Pathophysiology and management of radiation-induced xerostomia
J Support Oncol.
2005 May-Jun.
Abstract
Radiotherapeutic treatment of head and neck cancer patients often causes long-term dysfunction involving their salivary function, swallowing capabilities, and taste. Salivary gland dysfunction from radiation therapy is often the most unpleasant side effect of treatment. This article will review current knowledge concerning the anatomy and function of glands involved with salivation, measurement of salivary gland function, surgical and pharmacologic prevention and treatment of xerostomia, and methods to administer radiation while causing the least amount of damage to salivary glands.
Comment in
-
Reducing radiation-induced xerostomia with highly conformal radiotherapy techniques.J Support Oncol. 2005 May-Jun;3(3):201-2. J Support Oncol. 2005. PMID: 15915821 No abstract available.
-
Making a meaningful difference for the patient.J Support Oncol. 2005 May-Jun;3(3):207-8. J Support Oncol. 2005. PMID: 15915822 No abstract available.
Similar articles
-
Radiotherapy-induced salivary dysfunction.Semin Oncol. 2004 Dec;31(6 Suppl 18):29-36. doi: 10.1053/j.seminoncol.2004.12.009. Semin Oncol. 2004. PMID: 15726520 Review.
-
[Current status of prevention and management of radiation-induced xerostomia].Zhonghua Kou Qiang Yi Xue Za Zhi. 2010 Feb;45(2):121-3. Zhonghua Kou Qiang Yi Xue Za Zhi. 2010. PMID: 20368009 Review. Chinese. No abstract available.
-
Management of salivary hypofunction during and after radiotherapy.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103 Suppl:S66.e1-19. doi: 10.1016/j.tripleo.2006.11.013. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007. PMID: 17379158 Review.
-
Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.Curr Opin Oncol. 2006 May;18(3):266-70. doi: 10.1097/01.cco.0000219256.37843.83. Curr Opin Oncol. 2006. PMID: 16552239 Review.
-
A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.Semin Oncol. 2004 Dec;31(6 Suppl 18):25-8. doi: 10.1053/j.seminoncol.2004.12.008. Semin Oncol. 2004. PMID: 15726519 Clinical Trial.
Cited by
-
Photoacoustic monitoring of tumor and normal tissue response to radiation.Sci Rep. 2016 Feb 17;6:21237. doi: 10.1038/srep21237. Sci Rep. 2016. PMID: 26883660 Free PMC article.
-
Localized Delivery of Amifostine Enhances Salivary Gland Radioprotection.J Dent Res. 2018 Oct;97(11):1252-1259. doi: 10.1177/0022034518767408. Epub 2018 Apr 10. J Dent Res. 2018. PMID: 29634396 Free PMC article.
-
A study on Evaluation of efficacy of bethanechol in the management of chemoradiation-induced xerostomia in oral cancer patients.J Oral Maxillofac Pathol. 2017 Sep-Dec;21(3):459-460. doi: 10.4103/jomfp.JOMFP_72_16. J Oral Maxillofac Pathol. 2017. PMID: 29391733 Free PMC article.
-
"Dry mouth" and "Flammer" syndromes-neglected risks in adolescents and new concepts by predictive, preventive and personalised approach.EPMA J. 2018 Aug 2;9(3):307-317. doi: 10.1007/s13167-018-0145-7. eCollection 2018 Sep. EPMA J. 2018. PMID: 30174766 Free PMC article.
-
Acupuncture for the treatment of radiation-induced xerostomia among patients with cancer: A protocol for a systematic review and meta-analysis.Medicine (Baltimore). 2020 Jun 12;99(24):e20658. doi: 10.1097/MD.0000000000020658. Medicine (Baltimore). 2020. PMID: 32541507 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical